Re: Just back from IR,...
in response to
by
posted on
Oct 26, 2019 02:11PM
In addition to the primary results, we look forward to reporting our secondary and exploratory endpoints in the near future,” commented Dr. Michael Sweeney, Senior Vice President, Clinical Development of the Company.